Kraig Biocraft Laboratories is focused on genetically engineering next-generation polymers with unprecedented capabilities, such as recombinant spider silk.
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States.
Kraig Biocraft Laboratories, Inc. operates as a biotechnology company, which focuses on the development and commercialization of spider silk. It specializes in the global textiles industry ...
KBLB Stock Price | Kraig Biocraft Laboratories Inc. Stock Quote (U.S ...
Kraig Biocraft Laboratories, Inc. is an American biotechnology company headquartered in Ann Arbor, Michigan. It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences. [1] .
ANN ARBOR, Mich., – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that it has begun processing nearly 1.8 metric tons of recombinant spider silk cocoons into finished reeled silk.
Kraig Labs completed the development of three new spider silk strains, which are now in the field. These strains, developed over the last year, were designed to complement the Company’s existing BAM-1 hybrid by improving hybrid vigor and increasing silk yield.
Kraig Biocraft Laboratories, a leader in spider silk technology, has announced that it has begun processing nearly 1.8 metric tons of recombinant spider silk cocoons into finished reeled silk. This represents the largest single supply of recombinant spider silk ever produced. The company expects to hold the largest inventory of spider silk in its history once this processing is complete.